TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←
▶ 14:22 · $LLY · Druckenmiller profited from Eli Lilly's GLP-1 obesity drugs viewing it as razor-blade recurring revenue model
episode briefing
In Good Company with Nicolai Tangen

Stan Druckenmiller | Podcast | In Good Company | Norges Bank Investment Management

2024-11-06 · 3 company · 5 thematic
sentiment
1 bull1 bear1 neu
speakers
stan druckenmiller

Stan Druckenmiller is a legendary investor who ran Duquesne Capital for 30 years and managed George Soros's Quantum Fund, famously breaking the Bank of England in 1992. He now runs a family office and is known for macro investing across asset classes with concentrated positions.

quote
“you were also early into the anti-obesity drug producers oh that was easy I mean I don't know what it's like in Norway but in America yeah if you go to Disney World everything and if you know the American psyche if you know an American the…”
—stan druckenmiller
now playing · $LLY
$US10Y···bearish· high· posstan druckenmiller
Druckenmiller short 10-year Treasuries at 25% NAV betting on inflation resurgence and failed auction risk
Shorting 10-year Treasury equivalents (25% of NAV) because Fed cutting 50bps into tight financial conditions, gold highs, roaring equities, and 7% deficit at full employment risks…
$NVDA···neutral· mediumstan druckenmiller
Druckenmiller bought Nvidia early on AI thesis but sold at $800-900 as valuation exceeded $2T
Bought Nvidia as picks-and-shovels AI play after young analysts flagged engineer shift from crypto to AI; sold when market cap surpassed $2T viewing it as cyclical semiconductor a…
$LLY···bullish· mediumstan druckenmiller
Druckenmiller profited from Eli Lilly's GLP-1 obesity drugs viewing it as razor-blade recurring revenue model
Identified anti-obesity drugs early as structural winner because American consumers want weight loss without effort and must stay on drug indefinitely to maintain results, creatin…